Dry Age Related Macular Degeneration Clinical Trial
Official title:
Prospective, Randomized, Controlled Clinical Study Evaluating the Efficacy of Rheopheresis for Dry Age-Related Macular Degeneration Dry AMD Treatment With Rheopheresis Trial - ART
Purpose is to evaluate Rheopheresis for the treatment of patients with high-risk dry age-related macular degeneration and no therapeutic alternative. Rheopheresis is a method of therapeutic apheresis using the methodology of double filtration plasmapheresis to treat microcirculatory disorders.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT01674829 -
A PhaseI/IIa Study to Determine the Safety and Tolerability of MA09-hRPE Cells in Patients With Advanced Dry AMD
|
Phase 1/Phase 2 | |
| Enrolling by invitation |
NCT03305029 -
The Safety and Tolerability of Sub-retinal Transplantation of SCNT-hES-RPE Cells in Patients With Advanced Dry AMD
|
Phase 1 | |
| Completed |
NCT01344993 -
Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration
|
Phase 1/Phase 2 | |
| Completed |
NCT00804102 -
Transcorneal Electrical Stimulation Therapy for Retinal Disease
|
N/A | |
| Suspended |
NCT00541333 -
Weekly Vaccination With Copaxone as a Potential Therapy for Dry Age-related Macular Degeneration
|
Phase 1 | |
| Completed |
NCT00429936 -
Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration
|
Phase 2 |